Skip to main content

Donate Today

Every gift, no matter the size, helps change children’s lives.

Division of Hematology News

Every person on your child's team has the same goal: to see your child thrive. We provide medical care, emotional counseling and much more.

Contact us

Q&A with Dr. Stella Chou

Aug 14, 2026

Meet physician-scientist Stella T. Chou, MD, the new Chief of the Division of Hematology. Read about the promise of emerging therapies, what makes CHOP unique and more.

Analysis of Brain Tumor Following AAV Gene Therapy Identifies Vector Integration and Reinforces Importance of Long-Term Monitoring

May 13, 2026

CHOP researchers reported today in the New England Journal of Medicine about a rare but noteworthy outcome in a child treated with an adeno-associated virus (AAV) gene therapy for severe mucopolysaccharidosis type I (MPS I). MPS I, a lysosomal storage disorder also known as Hurler Syndrome, is characterized by an abnormal build-up of various toxic materials, called glycosaminoglycans (GAGs) in the body's cells.

Jump back to top